Neuroblastoma

Neuroblastoma is a malignant tumor of neural crest cells, the cells that give rise to the sympathetic nervous system, which is observed in children.

Cardiomyopathy

A myocardial disorder in which the heart muscle is structurally and functionally abnormal, in the absence of coronary artery disease, hypertension, valvular disease and congenital heart disease sufficient to cause the observed myocardial abnormality.


Total: 12

                       


(per page)
PMID (PMCID)
24776602
 FEMALE Infant, Newborn
A catecholamine-secreting neuroblastoma leading to hydrops fetalis.
Inoue T, Ito Y, Nakamura T, Matsuoka K, Sago H.
J Perinatol. 2014;34(5):405-7.
A case of fetal neuroblastoma of the right adrenal gland, with rapid development of hydrops fetalis due to catecholamine-induced cardiomyopathy, is reported.
23652880
 FEMALE Infant
Variants of cardiomyopathy and hypertension in neuroblastoma.
Kwok SY, Cheng FW, Lo AF, Leung WK, Yam MC, Li CK.
J Pediatr Hematol Oncol. 2014;36(3):e158-61.
Variants of cardiomyopathy and hypertension in neuroblastoma.
23652880
 FEMALE Infant
Variants of cardiomyopathy and hypertension in neuroblastoma.
Kwok SY, Cheng FW, Lo AF, Leung WK, Yam MC, Li CK.
J Pediatr Hematol Oncol. 2014;36(3):e158-61.
Catecholamine-associated cardiomyopathies caused by neuroblastoma have rarely been reported.
17066463
 FEMALE Infant
Neuroblastoma presenting with dilated cardiomyopathy.
Kato M, Hirata S, Kikuchi A, Ogawa K, Kishimoto H, Hanada R.
Pediatr Blood Cancer. 2008;50(2):391-2.
The prompt improvement of cardiac function following treatment of neuroblastoma suggested that cardiomyopathy in this patient was caused by the increase in catecholamines secreted by neuroblastoma and that reduction in catecholamines by treatment of neuroblastoma led to improvement in the cardiomyopathy.
17066463
 FEMALE Infant
Neuroblastoma presenting with dilated cardiomyopathy.
Kato M, Hirata S, Kikuchi A, Ogawa K, Kishimoto H, Hanada R.
Pediatr Blood Cancer. 2008;50(2):391-2.
The prompt improvement of cardiac function following treatment of neuroblastoma suggested that cardiomyopathy in this patient was caused by the increase in catecholamines secreted by neuroblastoma and that reduction in catecholamines by treatment of neuroblastoma led to improvement in the cardiomyopathy.
17066463
 FEMALE Infant
Neuroblastoma presenting with dilated cardiomyopathy.
Kato M, Hirata S, Kikuchi A, Ogawa K, Kishimoto H, Hanada R.
Pediatr Blood Cancer. 2008;50(2):391-2.
The prompt improvement of cardiac function following treatment of neuroblastoma suggested that cardiomyopathy in this patient was caused by the increase in catecholamines secreted by neuroblastoma and that reduction in catecholamines by treatment of neuroblastoma led to improvement in the cardiomyopathy.
17066463
 FEMALE Infant
Neuroblastoma presenting with dilated cardiomyopathy.
Kato M, Hirata S, Kikuchi A, Ogawa K, Kishimoto H, Hanada R.
Pediatr Blood Cancer. 2008;50(2):391-2.
The prompt improvement of cardiac function following treatment of neuroblastoma suggested that cardiomyopathy in this patient was caused by the increase in catecholamines secreted by neuroblastoma and that reduction in catecholamines by treatment of neuroblastoma led to improvement in the cardiomyopathy.
17066463
 FEMALE Infant
Neuroblastoma presenting with dilated cardiomyopathy.
Kato M, Hirata S, Kikuchi A, Ogawa K, Kishimoto H, Hanada R.
Pediatr Blood Cancer. 2008;50(2):391-2.
The prompt improvement of cardiac function following treatment of neuroblastoma suggested that cardiomyopathy in this patient was caused by the increase in catecholamines secreted by neuroblastoma and that reduction in catecholamines by treatment of neuroblastoma led to improvement in the cardiomyopathy.
17066463
 FEMALE Infant
Neuroblastoma presenting with dilated cardiomyopathy.
Kato M, Hirata S, Kikuchi A, Ogawa K, Kishimoto H, Hanada R.
Pediatr Blood Cancer. 2008;50(2):391-2.
The prompt improvement of cardiac function following treatment of neuroblastoma suggested that cardiomyopathy in this patient was caused by the increase in catecholamines secreted by neuroblastoma and that reduction in catecholamines by treatment of neuroblastoma led to improvement in the cardiomyopathy.
17066463
 FEMALE Infant
Neuroblastoma presenting with dilated cardiomyopathy.
Kato M, Hirata S, Kikuchi A, Ogawa K, Kishimoto H, Hanada R.
Pediatr Blood Cancer. 2008;50(2):391-2.
Cardiomyopathy was normalized by improvement of neuroblastoma.
9084706
 FEMALE Infant
[Cardiomyopathy induced by catecholamines in neuroblastoma].
Joseph T, Olivier B, Magnier S, Brugieres L, Casasoprana A.
Arch Pediatr. 1997;4(1):32-5.
[Cardiomyopathy induced by catecholamines in neuroblastoma].
9084706
 FEMALE Infant
[Cardiomyopathy induced by catecholamines in neuroblastoma].
Joseph T, Olivier B, Magnier S, Brugieres L, Casasoprana A.
Arch Pediatr. 1997;4(1):32-5.
The reason why such a cardiomyopathy has never been reported in patients with neuroblastoma remains unclear.